← Back to Search

Web-Based Training for Improving Skills (SERT Trial)

N/A

Waitlist Available

Led By Michael Boninger, MD

Research Sponsored by Michael Boninger

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Speak English as a primary language

Utilize a wheelchair for the majority of mobility (over 40 hours per week)

Timeline

Screening 3 weeks

Treatment Varies

Follow Up this measure is collected at baseline, pre- training, during the training, as well as at the 1 month and 6 month follow ups.

Awards & highlights

SERT Trial Summary

This trial will test an online training program to see if it is effective and how to make it more successful.

Who is the study for?

This trial is for individuals who primarily use a wheelchair (over 40 hours per week) and can transfer themselves independently, possibly with the help of equipment like sliding boards. Participants must speak English as their primary language. Those with pain that prohibits transfers, active use of lower limb muscles during transfers, or recent pressure sores are not eligible.Check my eligibility

What is being tested?

The study aims to evaluate the effectiveness of an independent transfer training program delivered through a web-based platform. It seeks to identify ways to enhance the success rate of participants in mastering online remote transfer training techniques.See study design

What are the potential side effects?

Since this trial involves educational and training interventions rather than medical treatments, traditional physical side effects are not applicable. However, participants may experience fatigue or discomfort from practicing new transfer techniques.

SERT Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I primarily speak English.

Select...

I use a wheelchair for most of my daily movements.

Select...

I use a seated pivot to move from one seat to another.

SERT Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ this measure is collected at baseline, pre- training, during the training, as well as at the 1 month and 6 month follow ups.

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~this measure is collected at baseline, pre- training, during the training, as well as at the 1 month and 6 month follow ups.

This trial's timeline: 3 weeks for screening, Varies for treatment, and this measure is collected at baseline, pre- training, during the training, as well as at the 1 month and 6 month follow ups. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in Transfer Assessment Instrument Questionnaires (TAI-Q)

Secondary outcome measures

Change in Patient Reported Outcomes Measurement Information System: Ability to Participate in Social Roles and Activities

Change in Patient Reported Outcomes Measurement Information System: Physical Function with Mobility Aid

Change in Patient Reported Outcomes Measurement Information System: Satisfaction with Social Roles & Activities

+1 more

SERT Trial Design

3Treatment groups

Experimental Treatment

Group I: Randomized TrainingExperimental Treatment1 Intervention

Individuals may decide to participate in the research study and agree to be randomized. These individuals will be immediately randomized into an immediate or a wait list control group. The immediate will receive the independent transfer training program after completing the baseline questionnaires. The wait list control group will wait approximately 6 months before receiving the independent transfer training program.

Group II: Immediate Training (with follow up)Experimental Treatment1 Intervention

Individuals may decide to participate in the research study, but do not want to be randomized. After consent is obtained, these individuals will be directed immediately to the baseline questionnaires (see above) before and after the independent transfer training. Participants may also be asked to complete a user satisfaction survey.

Group III: Immediate Training (no follow up)Experimental Treatment1 Intervention

Individuals may decide to participate in the research study training program, but not in any follow up questionnaires. This group will have immediate access to the independent transfer training materials. They will complete data collection measures embedded in the transfer training program, including demographics, Online Learning Readiness Scale (OLRS), Moorong Self Efficacy Scale (MSES), Patient Reported Outcome Measurement Information System (PROMIS), Transfer Assessment Instrument Questionnaire (TAI-Q), and the Wheelchair User Shoulder Pain Index (WUSPI).

0 / 3Eligibility criteria met

Find a Location

Who is running the clinical trial?

Michael BoningerLead Sponsor

2 Previous Clinical Trials

31 Total Patients Enrolled

Department of Health and Human ServicesFED

226 Previous Clinical Trials

928,749 Total Patients Enrolled

University of PittsburghLead Sponsor

1,719 Previous Clinical Trials

16,342,141 Total Patients Enrolled

Media Library

Independent Transfer Training Clinical Trial Eligibility Overview. Trial Name: NCT03164278 — N/A

Remote Transfer Training Program Research Study Groups: Immediate Training (with follow up), Randomized Training, Immediate Training (no follow up)

Remote Transfer Training Program Clinical Trial 2023: Independent Transfer Training Highlights & Side Effects. Trial Name: NCT03164278 — N/A

Independent Transfer Training 2023 Treatment Timeline for Medical Study. Trial Name: NCT03164278 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this trial accommodating seniors aged 65 and above?

"This clinical trial is targeting participants who are between 18 and 75 years of age."

Answered by AI

Are there any unoccupied slots left in this investigation?

"The information publicly available on clinicaltrials.gov reveals that, despite being listed since December 4th 2017, this medical trial is not currently accepting participants. However, there are 1 other trials actively searching for suitable candidates at the moment."

Answered by AI

May I enroll in this clinical trial?

"The scope of this study is comprised of 200 participants, between the ages 18 and 75, who are already enrolled in a remote transfer training program. Additionally, to be eligible for inclusion individuals must regularly use wheelchairs (for more than 40 hours weekly), have experience with seated pivot transfers, and possess sufficient strength to independently move their body using specialized equipment such as sliding boards."

Answered by AI